Ponce M Lourdes, Kleinman Hynda K
Craniofacial Developmental Biology and Regeneration Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA.
Exp Cell Res. 2003 May 1;285(2):189-95. doi: 10.1016/s0014-4827(03)00056-9.
The degradation of the extracellular matrix is one of the first steps involved in angiogenesis, the formation of new vessels from preexisting ones. Laminin, a large extracellular matrix protein, has many biological activities, including the promotion of angiogenesis. Screening of the laminin-1 chains identified 20 angiogenic peptides, of which, A13 and C16, from the alpha1 and gamma1 chains, respectively, were the most active. We recently identified the receptors for C16 as the integrins alpha5beta1 and alphavbeta3. Here, we show unexpectedly that A13 is a redundant active site to C16 present in the N-terminal globular domain of the alpha1 chain. The peptides are located in homologous sites present in the last globular domains of their respective chains, and their amino acids are 66% conserved, as compared to the inactive homologous site in the beta1 chain, B19 to B20, which is only 18%-23% conserved. Cell attachment studies demonstrated that both A13 and C16 reciprocally inhibited their adhesion activity, whereas the corresponding laminin beta1 chain peptides were inactive. Chorioallantoic membrane assays showed that the in vivo angiogenic activity of A13 is blocked by a C16 antagonist, C16S, which also binds to the same integrin receptors. A13 affinity chromatography and immunoprecipitation analysis showed that the alphavbeta3 and alpha5beta1 integrin receptors bind to this sequence. We have therefore identified redundant activity on two laminin chains. These highly conserved functional sites are likely important mediators of the biological responses of laminins because either one or both of these chains (active sites) are present in almost all laminin isoforms identified to date.
细胞外基质的降解是血管生成(即从已有的血管形成新血管)所涉及的首要步骤之一。层粘连蛋白是一种大型细胞外基质蛋白,具有多种生物学活性,包括促进血管生成。对层粘连蛋白-1链的筛选鉴定出20种血管生成肽,其中分别来自α1链和γ1链的A13和C16活性最强。我们最近确定C16的受体为整合素α5β1和αvβ3。在此,我们意外地发现A13是α1链N端球状结构域中与C16冗余的活性位点。这些肽位于各自链的最后一个球状结构域中的同源位点,与β1链中无活性的同源位点B19至B20相比,它们的氨基酸有66%是保守的,而B19至B20的保守度仅为18%-23%。细胞黏附研究表明,A13和C16相互抑制彼此的黏附活性,而相应的层粘连蛋白β1链肽则无活性。尿囊膜试验表明,A13的体内血管生成活性被C16拮抗剂C16S阻断,C16S也与相同的整合素受体结合。A13亲和层析和免疫沉淀分析表明,αvβ3和α5β1整合素受体与该序列结合。因此,我们在两条层粘连蛋白链上鉴定出了冗余活性。这些高度保守的功能位点可能是层粘连蛋白生物学反应的重要介质,因为几乎所有迄今鉴定出的层粘连蛋白异构体中都存在这一条或两条链(活性位点)。